157 related articles for article (PubMed ID: 7364978)
1. Successful treatment of keratoacanthoma with intralesional fluorouracil.
Goette DK; Odom RB
J Am Acad Dermatol; 1980 Mar; 2(3):212-6. PubMed ID: 7364978
[TBL] [Abstract][Full Text] [Related]
2. Treatment of keratoacanthomas with intralesional fluorouracil.
Odom RB; Goette DK
Arch Dermatol; 1978 Dec; 114(12):1779-83. PubMed ID: 736584
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
Kurtis B; Rosen T
J Dermatol Surg Oncol; 1980 Feb; 6(2):122-7. PubMed ID: 7354186
[TBL] [Abstract][Full Text] [Related]
4. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
Parker CM; Hanke CW
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
[TBL] [Abstract][Full Text] [Related]
5. Treatment of keratoacanthoma with topical application of fluorouracil.
Goette DK; Odom RB; Arrott JW; Diakon NC; Horn RT
Arch Dermatol; 1982 May; 118(5):309-11. PubMed ID: 7082021
[TBL] [Abstract][Full Text] [Related]
6. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
Nofal A; Alakad R; Wahid R; Hoseiny HAM
Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
[TBL] [Abstract][Full Text] [Related]
7. Treatment of multiple keratoacanthomas with intralesional fluorouracil.
Eubanks SW; Gentry RH; Patterson JW; May DL
J Am Acad Dermatol; 1982 Jul; 7(1):126-9. PubMed ID: 7107992
[TBL] [Abstract][Full Text] [Related]
8. Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.
Seger EW; Tarantino IS; Neill BC; Wang T
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609455
[TBL] [Abstract][Full Text] [Related]
9. [The local treatment of the keratoacanthoma with 5-fluorouracil].
Ebner H; Mischer P
Hautarzt; 1975 Nov; 26(11):585-8. PubMed ID: 1205845
[TBL] [Abstract][Full Text] [Related]
10. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
11. Intralesional 5-fluorouracil for keratoacanthoma of the eyelid.
Bergin DJ; Lapins NA; Deffer TA
Ophthalmic Plast Reconstr Surg; 1986; 2(4):201-4. PubMed ID: 3154563
[TBL] [Abstract][Full Text] [Related]
12. Treatment of keratoacanthomas by local applications of the 5-fluorouracil (5-FU) ointment.
Grupper C
Dermatologica; 1970; 140():Suppl 1:127+. PubMed ID: 5471358
[No Abstract] [Full Text] [Related]
13. Treatment of keratoacanthomas with intralesional methotrexate.
Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
[TBL] [Abstract][Full Text] [Related]
14. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
Hoegler KM; Schleichert RA
J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
[No Abstract] [Full Text] [Related]
15. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
16. Unusual multiple keratoacanthoma in a child successfully treated with 5-fluorouracil.
Singal A; Mohanty S; Bhattacharya SN; Baruah MC; Singh N
J Dermatol; 1997 Aug; 24(8):546-8. PubMed ID: 9301151
[No Abstract] [Full Text] [Related]
17. Treatment of giant keratoacanthoma with intralesional 5-fluorouracil.
Leonard AL; Hanke CW
J Drugs Dermatol; 2006 May; 5(5):454-6. PubMed ID: 16703783
[TBL] [Abstract][Full Text] [Related]
18. Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Marka A; Rodgers D; Zelaya Castillo L; Hoyt B; Chapman M; Carter J
J Drugs Dermatol; 2023 May; 22(5):507-508. PubMed ID: 37133471
[TBL] [Abstract][Full Text] [Related]
19. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
[TBL] [Abstract][Full Text] [Related]
20. Intralesional methotrexate in keratoacanthoma of the nose.
Hurst LN; Gan BS
Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
